Outcomes of Saphenous Vein Graft Intervention with and Without Embolic Protection Device: A Comprehensive Review and Meta-Analysis

Circulation: Cardiovascular Interventions

Volumn 10, Issue 12, 2017, Pages

  Paul, Timir K ^a   Bhatheja, Samit ^a   Panchal, Hemang B ^a   Zheng, Shimin ^b   Banerjee, Subhash ^c,d   Rao, Sunil V ^e   Guzman, Luis ^f   Beohar, Nirat ^g,j   Zhao, David ^h   Mehran, Roxana ^c   Mukherjee, Debabrata ⁱ  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Workplace Health Group   (United States)

^c EAST TENNESSEE STATE UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^h MOUNT SINAI MEDICAL CENTER   (United States)

ⁱ WAKE FOREST UNIVERSITY   (United States)

^j TEXAS TECH UNIVERSITY   (United States)

more..

Author keywords

embolic protection device; meta analysis; mortality; myocardial infarction; percutaneous coronary intervention

Indexed keywords

ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR DISEASE; HEART INFARCTION; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SENSITIVITY ANALYSIS; TARGET VESSEL REVASCULARIZATION; AGED; CHI SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEVICES; EMBOLIC PROTECTION DEVICE; FEMALE; GRAFT OCCLUSION; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RISK FACTOR; SAPHENOUS VEIN; TIME FACTOR; TRANSPLANTATION; TREATMENT OUTCOME; UNNECESSARY PROCEDURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; EMBOLIC PROTECTION DEVICES; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RISK FACTORS; SAPHENOUS VEIN; TIME FACTORS; TREATMENT OUTCOME; UNNECESSARY PROCEDURES;

EID: 85038927588     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.117.005538     Document Type: Article

References (27)

1. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Kent KM, Satler LF, Stone GW, Leon MB, Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999 100 2400 2405
2. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP Jr, Kuntz RE, Baim DS, Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994 89 2514 2518
3. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH, 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011 124 e574 e651. doi: 10.1161/CIR.0b013e31823ba622.
4. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE, Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002 105 1285 1290
5. Dixon SR, Mann JT, Lauer MA, Casale PN, Dippel EJ, Strumpf RK, Feldman RL, Shear W, Resar JR, Zimmer SD, O'Neill WW, TRAP Investigators A randomized, controlled trial of saphenous vein graft intervention with a filter-based distal embolic protection device: TRAP trial. J Interv Cardiol 2005 18 233 241. doi: 10.1111/j.1540-8183.2005.00039.x.
6. Golwala H, Hawkins BM, Stavrakis S, Abu-Fadel MS, Embolic protection device use and outcomes in patients receiving saphenous vein graft interventions-a single-center experience. J Invasive Cardiol 2012 24 1 3
7. Iqbal MB, Nadra IJ, Ding L, Fung A, Aymong E, Chan AW, Hodge S, Della Siega A, Robinson SD, British Columbia Cardiac Registry Investigators Embolic protection device use and its association with procedural safety and long-term outcomes following saphenous vein graft intervention: an analysis from the British Columbia Cardiac registry. Catheter Cardiovasc Interv 2016 88 73 83. doi: 10.1002/ccd.26237.
8. Lavi S, Ivanov J, Appleby CE, Seidelin PH, Mackie K, Schwartz L, Dzavík V, Selective use of embolic protection devices during saphenous vein grafts interventions: a single-center experience. Catheter Cardiovasc Interv 2010 75 1037 1044. doi: 10.1002/ccd.22392.
9. Matar FA, Smith K, Rossi P, Vandormael M, Sullebarger JT, Taylor M, Caruncho C, Ali T, Kerensky R, Limitations of embolic protection in saphenous vein graft intervention: insights from 202 consecutive patients. J Interv Cardiol 2009 22 240 246. doi: 10.1111/j.1540-8183.2009.00465.x.
10. Sadr-Ameli M, Mousavi H, Heidarali M, Maadani M, Ghelich Y, Ghadrdoost B, Early and midterm major adverse cardiac events in patient with saphenous vein graft using direct stenting or embolic protection device stenting. Res Cardiovasc Med 2014 3 e13012. doi: 10.5812/cardiovascmed.13012.
11. Brennan JM, Al-Hejily W, Dai D, Shaw RE, Trilesskaya M, Rao SV, Brilakis ES, Anstrom KJ, Messenger JC, Peterson ED, Douglas PS, Sketch MH, Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry. Circ Cardiovasc Interv 2015 8 e001403. doi: 10.1161/CIRCINTERVENTIONS.114.001403.
12. Abdel-Karim AR, Papayannis AC, Mahmood A, Michael TT, Rangan BV, Makke L, Banerjee S, Brilakis ES, Role of embolic protection devices in ostial saphenous vein graft lesions. Catheter Cardiovasc Interv 2012 80 1120 1126. doi: 10.1002/ccd.23471.
13. Mehilli J, Pache J, Abdel-Wahab M, Schulz S, Byrne RA, Tiroch K, Hausleiter J, Seyfarth M, Ott I, Ibrahim T, Fusaro M, Laugwitz KL, Massberg S, Neumann FJ, Richardt G, Schömig A, Kastrati A, Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? (ISAR-CABG) Investigators Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. Lancet 2011 378 1071 1078. doi: 10.1016/S0140-6736(11)61255-5.
14. Senter SR, Nathan S, Gupta A, Klein LW, Clinical and economic outcomes of embolic complications and strategies for distal embolic protection during percutaneous coronary intervention in saphenous vein grafts. J Invasive Cardiol 2006 18 49 53
15. Lee MS, Park SJ, Kandzari DE, Kirtane AJ, Fearon WF, Brilakis ES, Vermeersch P, Kim YH, Waksman R, Mehilli J, Mauri L, Stone GW, Saphenous vein graft intervention. JACC Cardiovasc Interv 2011 4 831 843. doi: 10.1016/j.jcin.2011.05.014.
16. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009 6 e1000100. doi: 10.1371/journal.pmed.1000100.
17. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000 283 2008 2012
18. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA, FilterWire EX Randomized Evaluation Investigators Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003 108 548 553. doi: 10.1161/01.CIR.0000080894.51311.0A.
19. Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Pavliska J, Wahr D, Rogers C, The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol 2007 50 1442 1449. doi: 10.1016/j.jacc.2007.06.039.
20. Carrozza JP Jr, Mumma M, Breall JA, Fernandez A, Heyman E, Metzger C, PRIDE Study Investigators Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol 2005 46 1677 1683. doi: 10.1016/j.jacc.2005.06.073.
21. Sievert H, Wahr DW, Schuler G, Schofer JJ, Sutsch G, Pavliska J, Skowasch M, Effectiveness and safety of the Proxis system in demonstrating retrograde coronary blood flow during proximal occlusion and in capturing embolic material. Am J Cardiol 2004 94 1134 1139. doi: 10.1016/j.amjcard.2004.07.079.
22. von Korn H, Yu J, Huegl B, Wagner A, Ohlow M, Lauer B, Safety and efficacy of a new filter-based protection system for aorto-coronary bypass graft interventions: the ev3 Spider device. J Invasive Cardiol 2005 17 352 355
23. Mehta SK, Frutkin AD, Milford-Beland S, Klein LW, Shaw RE, Weintraub WS, Krone RJ, Anderson HV, Kutcher MA, Marso SP, American College of Cardiology-National Cardiovascular Data Registry Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol 2007 100 1114 1118. doi: 10.1016/j.amjcard.2007.04.058.
24. Mathew V, Lennon RJ, Rihal CS, Bresnahan JF, Holmes DR Jr, Applicability of distal protection for aortocoronary vein graft interventions in clinical practice. Catheter Cardiovasc Interv 2004 63 148 151. doi: 10.1002/ccd.20102.
25. Leborgne L, Cheneau E, Pichard A, Ajani A, Pakala R, Yazdi H, Satler L, Kent K, Suddath WO, Pinnow E, Canos D, Waksman R, Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. Am Heart J 2003 146 501 506. doi: 10.1016/S0002-8703(03)00309-0.
26. Fischell TA, Subraya RG, Ashraf K, Perry B, Haller S, "Pharmacologic" distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention. J Invasive Cardiol 2007 19 58 62
27. Sharma S, Lardizabal JA, Singh S, Sandhu R, Bhambi BK, Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus. Recent Pat Cardiovasc Drug Discov 2012 7 152 159